Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Outsourcing in Clinical Trials New England 2022

Outsourcing in Clinical Trials New England 2022

October 12-13, 2022 | Boston, MA

We are excited to share that we will be attending and exhibiting at Outsourcing in Clinical Trials New England in Boston on October 12th-13th. The agenda for this year’s event will focus on promoting successful collaboration between parties in the clinical trials community and providing attendees with practical take-aways they can apply to their own studies.

The event will consist of 4 tracks:

  • Clinical Operations & Outsourcing
  • Decentralized & Hybrid Trials
  • Rare Disease Trials
  • Technology, Innovation & Devices

Join us in Boston for a networking focused event with industry leading presentations, interactive sessions, and the most innovative solution providers in attendance.

Events
Category:
Clinical Operations Clinical Trials Healthcare Technology Hybrid Clinical Trials Rare Disease
Published on:
September 20, 2022
Our delegates
Bridget Bojic

Bridget Bojic

 Associate Manager, Clinical Development, Alira Health

Brendan Wrigley

 Manager, Clinical Development, Alira Health

Would you like to meet Alira Health at OCT New England in Boston? Contact us to set up a meeting.

Additional Clinical Trial Resources:

Diversity in Clinical Trials: A Blog Series
How to Integrate the Patient Voice in Rare Disease Clinical Trials

Contact us

Related news

Uncategorized April 8, 2025
Alira Health et Euris Health Cloud collaborent avec Gustave Roussy pour le développement de la plateforme digitale d’Interception
Alira Health est fière de collaborer en tant que partenaire commercial au développement numérique du projet Interception, une initiative pionnière dans le domaine de la prévention(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
Events March 12, 2025
Healthtech Accelerations Summit 2025
Meet our experts to discover how we support companies bring innovation to patients by structuring drug development into clear, achievable inflection points.
Biotech Drug Development EU Healthcare Technology
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
News February 27, 2025
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
Articles February 24, 2025
New Regulation on Health Technology Assessment: Impact in France
Discover the new Regulation on Health Technology Assessment impacts on market access processes in France.
EU Healthcare Technology Regulatory
Articles February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity Pharma Rare Disease
Articles February 11, 2025
From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey
For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.
Patient Centricity Pharma Rare Disease
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.